DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,798 filers reported holding DANAHER CORPORATION in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48,852,875 | +4.0% | 196,908 | +0.6% | 0.94% | +9.7% |
| Q2 2023 | $46,974,000 | +6.6% | 195,725 | +12.0% | 0.85% | -3.6% |
| Q1 2023 | $44,053,568 | -1.2% | 174,788 | +4.0% | 0.88% | -8.0% |
| Q4 2022 | $44,590,825 | +2.9% | 168,001 | +0.1% | 0.96% | -0.6% |
| Q3 2022 | $43,344,000 | -41.7% | 167,813 | -42.8% | 0.97% | -6.2% |
| Q2 2022 | $74,387,000 | -12.4% | 293,418 | +1.3% | 1.03% | +8.4% |
| Q1 2022 | $84,928,000 | -16.6% | 289,532 | -6.4% | 0.95% | +0.5% |
| Q4 2021 | $101,810,000 | +7.4% | 309,442 | -0.6% | 0.95% | +3.6% |
| Q3 2021 | $94,759,000 | +0.7% | 311,257 | -11.2% | 0.91% | +8.9% |
| Q2 2021 | $94,111,000 | +15.0% | 350,691 | -3.5% | 0.84% | +10.4% |
| Q1 2021 | $81,817,000 | -5.4% | 363,501 | -6.6% | 0.76% | -5.2% |
| Q4 2020 | $86,470,000 | -11.4% | 389,260 | -14.2% | 0.80% | -25.4% |
| Q3 2020 | $97,651,000 | +17.5% | 453,494 | -3.5% | 1.08% | +6.0% |
| Q2 2020 | $83,121,000 | +16.5% | 470,063 | -8.8% | 1.01% | -15.6% |
| Q1 2020 | $71,370,000 | -13.3% | 515,645 | -3.8% | 1.20% | +5.1% |
| Q4 2019 | $82,292,000 | +3.1% | 536,176 | -2.9% | 1.14% | -4.7% |
| Q3 2019 | $79,785,000 | +621.5% | 552,410 | +613.9% | 1.20% | +55.4% |
| Q2 2019 | $11,058,000 | +99.4% | 77,378 | +84.2% | 0.77% | +17.1% |
| Q1 2019 | $5,547,000 | +27.8% | 42,014 | -0.2% | 0.66% | +11.3% |
| Q4 2018 | $4,342,000 | -8.5% | 42,103 | -3.6% | 0.59% | -4.4% |
| Q3 2018 | $4,746,000 | +47.7% | 43,676 | +34.1% | 0.62% | +26.3% |
| Q2 2018 | $3,214,000 | -3.9% | 32,570 | -4.7% | 0.49% | +1.4% |
| Q1 2018 | $3,346,000 | -13.9% | 34,170 | -18.4% | 0.48% | -16.3% |
| Q4 2017 | $3,886,000 | -15.8% | 41,870 | -22.2% | 0.58% | -14.4% |
| Q3 2017 | $4,615,000 | -16.4% | 53,800 | -17.7% | 0.68% | -14.4% |
| Q2 2017 | $5,519,000 | -25.1% | 65,400 | -24.0% | 0.79% | -12.0% |
| Q1 2017 | $7,364,000 | +8.4% | 86,100 | -1.4% | 0.90% | +6.2% |
| Q4 2016 | $6,795,000 | +35.2% | 87,300 | +36.2% | 0.84% | +41.5% |
| Q3 2016 | $5,025,000 | -27.5% | 64,100 | -6.6% | 0.60% | -28.4% |
| Q2 2016 | $6,929,000 | -12.3% | 68,600 | -17.6% | 0.83% | -3.8% |
| Q1 2016 | $7,899,000 | -37.1% | 83,268 | -38.4% | 0.87% | -22.2% |
| Q4 2015 | $12,562,000 | +16.7% | 135,248 | +7.0% | 1.11% | +14.0% |
| Q3 2015 | $10,766,000 | -4.2% | 126,348 | -3.8% | 0.98% | +21.2% |
| Q2 2015 | $11,242,000 | -6.8% | 131,348 | -7.5% | 0.81% | -11.1% |
| Q1 2015 | $12,060,000 | -17.9% | 142,048 | -17.1% | 0.91% | -10.7% |
| Q4 2014 | $14,695,000 | -18.8% | 171,448 | -28.0% | 1.02% | -9.8% |
| Q3 2014 | $18,102,000 | -20.1% | 238,248 | -17.3% | 1.13% | -5.8% |
| Q2 2014 | $22,670,000 | -22.1% | 287,948 | -25.8% | 1.20% | -6.8% |
| Q1 2014 | $29,089,000 | -15.6% | 387,848 | -13.1% | 1.28% | -13.5% |
| Q4 2013 | $34,450,000 | +8.9% | 446,248 | -2.2% | 1.48% | +5.8% |
| Q3 2013 | $31,634,000 | -37.6% | 456,348 | -43.0% | 1.40% | -23.8% |
| Q2 2013 | $50,662,000 | – | 800,348 | – | 1.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |